Terms: = Liver cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Treatment
120 results:
1. Adverse events of neoadjuvant combination immunotherapy for resectable cancer patients: a systematic review and meta-analysis.
Feng Y; Guo K; Jin H; Jiang J; Wang M; Lin S
Front Immunol; 2023; 14():1269067. PubMed ID: 38250059
[TBL] [Abstract] [Full Text] [Related]
2. Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
Flecchia C; Auclin E; Alouani E; Mercier M; Hollebecque A; Turpin A; Mazard T; Pernot S; Dutherage M; Cohen R; Borg C; Hautefeuille V; Sclafani F; Ben-Abdelghani M; Aparicio T; De La Fouchardière C; Herve C; Perkins G; Heinrich K; Kunzmann V; Gallois C; Guimbaud R; Tougeron D; Taieb J
Br J Cancer; 2024 Feb; 130(3):442-449. PubMed ID: 38102227
[TBL] [Abstract] [Full Text] [Related]
3. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Llovet JM; Kudo M; Merle P; Meyer T; Qin S; Ikeda M; Xu R; Edeline J; Ryoo BY; Ren Z; Masi G; Kwiatkowski M; Lim HY; Kim JH; Breder V; Kumada H; Cheng AL; Galle PR; Kaneko S; Wang A; Mody K; Dutcus C; Dubrovsky L; Siegel AB; Finn RS;
Lancet Oncol; 2023 Dec; 24(12):1399-1410. PubMed ID: 38039993
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
5. CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis.
Behrouzi R; Armstrong AC; Howell SJ
Breast Cancer Res Treat; 2023 Nov; 202(1):83-95. PubMed ID: 37584881
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.
Huang J; Wang ZG; Tao QF; Yang Y; Yuan SX; Gu FM; Liu H; Pan ZY; Jiang BG; Lau WY; Zhou WP
Front Immunol; 2023; 14():1198562. PubMed ID: 37483609
[TBL] [Abstract] [Full Text] [Related]
7. Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
de Mestier L; Resche-Rigon M; Dromain C; Lamarca A; La Salvia A; de Baker L; Fehrenbach U; Pusceddu S; Colao A; Borbath I; de Haas R; Rinzivillo M; Zerbi A; Funicelli L; de Herder WW; Selberherr A; Wagner AD; Manoharan P; De Cima A; Lybaert W; Jann H; Prinzi N; Faggiano A; Annet L; Walenkamp A; Panzuto F; Pedicini V; Pitoni MG; Siebenhuener A; Mayerhoefer ME; Ruszniewski P; Vullierme MP
J Neuroendocrinol; 2023 Jun; 35(6):e13311. PubMed ID: 37345276
[TBL] [Abstract] [Full Text] [Related]
8. treatment outcome comparisons of first-line targeted therapy in patients with KRAS wild-type metastatic colorectal cancer: A nationwide database study.
Liang YH; Chen KH; Shao YY
Cancer Med; 2023 Jul; 12(14):15176-15186. PubMed ID: 37325970
[TBL] [Abstract] [Full Text] [Related]
9. A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease.
Xu K; Gao J; Feng L; Fang Y; Tang X
Front Immunol; 2023; 14():1203876. PubMed ID: 37292208
[TBL] [Abstract] [Full Text] [Related]
10. Risk Factors and Outcomes of Open Conversion During Minimally Invasive Major Hepatectomies: An International Multicenter Study on 3880 Procedures Comparing the Laparoscopic and Robotic Approaches.
Montalti R; Giglio MC; Wu AGR; Cipriani F; D'Silva M; Suhool A; Nghia PP; Kato Y; Lim C; Herman P; Coelho FF; Schmelzle M; Pratschke J; Aghayan DL; Liu Q; Marino MV; Belli A; Chiow AKH; Sucandy I; Ivanecz A; Di Benedetto F; Choi SH; Lee JH; Park JO; Prieto M; Guzman Y; Fondevila C; Efanov M; Rotellar F; Choi GH; Robles-Campos R; Wang X; Sutcliffe RP; Tang CN; Chong CC; D'Hondt M; Dalla Valle B; Ruzzenente A; Kingham TP; Scatton O; Liu R; Mejia A; Mishima K; Wakabayashi G; Lopez-Ben S; Pascual F; Cherqui D; Forchino F; Ferrero A; Ettorre GM; Levi Sandri GB; Sugioka A; Edwin B; Cheung TT; Long TCD; Abu Hilal M; Aldrighetti L; Fuks D; Han HS; Troisi RI; Goh BKP;
Ann Surg Oncol; 2023 Aug; 30(8):4783-4796. PubMed ID: 37202573
[TBL] [Abstract] [Full Text] [Related]
11. Contrast-enhanced CT parameters predict short-term tumor response in patients with hepatocellular carcinoma who received sequential combined anti-angiogenesis and immune checkpoint inhibitor treatment.
Feng Y; Zhang H; Ren Q; Li C; Liu S; Zheng C; Xia X
Eur J Radiol; 2023 May; 162():110784. PubMed ID: 36958125
[TBL] [Abstract] [Full Text] [Related]
12. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract] [Full Text] [Related]
13. Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma.
Sun Z; Shi Z; Xin Y; Zhao S; Jiang H; Li J; Li J; Jiang H
Acad Radiol; 2023 Sep; 30 Suppl 1():S81-S91. PubMed ID: 36803649
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and safety of no-touch radiofrequency ablation for small hepatocellular carcinoma-a systematic review and single-arm meta-analysis.
Du F; Zhang L; Zhang Y; Fan H; Ren L
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102069. PubMed ID: 36513251
[TBL] [Abstract] [Full Text] [Related]
15. Utility of combined gadoxetic acid and ferumoxytol-enhanced liver MRI for preoperative detection of colorectal cancer liver metastases: a pilot study.
Carney BW; Gholami S; Fananapazir G; Sekhon S; Lamba R; Loehfelm TW; Wilson MD; Corwin MT
Acta Radiol; 2023 Apr; 64(4):1357-1362. PubMed ID: 36437569
[TBL] [Abstract] [Full Text] [Related]
16. Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.
Chen S; Guan L; Zhao X; Yang J; Chen L; Guo M; Zhao J; Chen C; Zhou Y; Han Y; Xu L
J Zhejiang Univ Sci B; 2022 Nov; 23(11):915-930. PubMed ID: 36379611
[TBL] [Abstract] [Full Text] [Related]
17. External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney cancer Consortium (TKCC) Database.
Yekedüz E; Karakaya S; Ertürk İ; Tural D; Uçar G; Şentürk Öztaş N; Arıkan R; Hızal M; Küçükarda A; Sever ÖN; Arslan Ç; Can O; Kılıçkap S; Yazgan C; Karadurmuş N; Şendur MA; Çiçin İ; Demirci U; Özgüroğlu M; Öksüzoğlu B; Ürün Y
Clin Genitourin Cancer; 2023 Feb; 21(1):175-182. PubMed ID: 35970759
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer.
Kazama H; Kawaguchi O; Seto T; Suzuki K; Matsuyama H; Matsubara N; Tajima Y; Fukao T
BMC Cancer; 2022 Apr; 22(1):470. PubMed ID: 35484517
[TBL] [Abstract] [Full Text] [Related]
19. Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.
Tada T; Kumada T; Hiraoka A; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Tanaka T; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Naganuma A; Koizumi Y; Nakamura S; Joko K; Iijima H; Hiasa Y;
Cancer Med; 2022 Oct; 11(20):3796-3808. PubMed ID: 35441477
[TBL] [Abstract] [Full Text] [Related]
20. Changes in Body Composition Predict the Time to treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study.
Yamamoto T; Imai N; Kuzuya T; Yokoyama S; Yamamoto K; Ito T; Ishizu Y; Honda T; Ishigami M
Nutr Cancer; 2022; 74(9):3118-3127. PubMed ID: 35285364
[TBL] [Abstract] [Full Text] [Related]
[Next]
